13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001172661-25-003478
Total Value
$153.8M
Positions
26
Other Managers
2
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IONIS PHARMACEUTICALS INC | IONS | 500,000 | $19.8M | 12.84% |
| 2 | REZOLUTE INC | RZLT | 3,033,462 | $13.5M | 8.80% |
| 3 | AMYLYX PHARMACEUTICALS INC | AMLX | 2,000,000 | $12.8M | 8.34% |
| 4 | LEGEND BIOTECH CORP | LEGN | 350,000 | $12.4M | 8.08% |
| 5 | ABIVAX SA | AAVXF | 1,291,617 | $9.9M | 6.42% |
| 6 | NEUROGENE INC | NGNE | 485,859 | $7.3M | 4.72% |
| 7 | AKEBIA THERAPEUTICS INC | AKBA | 1,985,915 | $7.2M | 4.70% |
| 8 | EVOLUS INC | EOLS | 720,118 | $6.6M | 4.31% |
| 9 | ARCELLX INC | ACLX | 100,000 | $6.6M | 4.28% |
| 10 | XENON PHARMACEUTICALS INC | XENE | 200,000 | $6.3M | 4.07% |
| 11 | AKERO THERAPEUTICS INC | 00973Y108 | 103,848 | $5.5M | 3.60% |
| 12 | JADE BIOSCIENCES INC | JBIO | 498,054 | $5.0M | 3.24% |
| 13 | CYTOKINETICS INC | CYTK | 150,000 | $5.0M | 3.22% |
| 14 | IMMUNOVANT INC | IMVT | 262,176 | $4.2M | 2.73% |
| 15 | UNICYCIVE THERAPEUTICS INC | UNCY | 796,558 | $3.8M | 2.47% |
| 16 | KALVISTA PHARMACEUTICALS INC | KALV | 323,170 | $3.7M | 2.38% |
| 17 | TAYSHA GENE THERAPIES INC | TSHA | 1,500,000 | $3.5M | 2.25% |
| 18 | DBV TECHNOLOGIES S A | DBVTF | 374,679 | $3.4M | 2.23% |
| 19 | ZURA BIO LTD | ZURA | 3,170,194 | $3.3M | 2.16% |
| 20 | UPSTREAM BIO INC | UPB | 300,000 | $3.3M | 2.14% |
| 21 | CONTEXT THERAPEUTICS INC | CNTX | 4,683,711 | $3.1M | 2.00% |
| 22 | CENTESSA PHARMACEUTICALS PLC | CNTA | 225,000 | $3.0M | 1.92% |
| 23 | SCHOLAR ROCK HLDG CORP | SRRK | 61,607 | $2.2M | 1.42% |
| 24 | PROMIS NEUROSCIENCES INC | PMN | 2,645,128 | $1.3M | 0.83% |
| 25 | PLIANT THERAPEUTICS INC | PLRX | 850,000 | $986,000 | 0.64% |
| 26 | HELIX ACQUISITION CORP II | HLXC | 29,381 | $312,026 | 0.20% |